Name: Xpert Mtb/Rif Implementation Manual: Technical and Operational How-To: Practical Considerations (en Inglés)
SKU: 57713480
Price: 645.47 MXN
Availability: InStock
Author: World Health Organization
ISBN: 9789241506700

portada Xpert Mtb/Rif Implementation Manual: Technical and Operational How-To: Practical Considerations (en Inglés)

Xpert Mtb/Rif Implementation Manual: Technical and Operational How-To: Practical Considerations (en Inglés)

Formato

Libro Físico

Autor

World Health Organization

Editorial

World Health Organization

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

23.4x15.5x0.5 cm

Peso

0.14 kg.

ISBN13

9789241506700

Categorías

Salud pública y medicina preventiva

Xpert Mtb/Rif Implementation Manual: Technical and Operational How-To: Practical Considerations (en Inglés)

World Health Organization (Autor) · World Health Organization · Tapa Blanda

Libro Nuevo Importado

Envío: 18 a 24 días háb.

$ 1,173.58$ 645.47

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 11 unidades

$ 645.47

¡Envío Gratis! Llega entre el 20 Nov y el 01 Dic a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Xpert Mtb/Rif Implementation Manual: Technical and Operational How-To: Practical Considerations (en Inglés)"

In December 2010, WHO first recommended the use of the Xpert MTB/RIF assay. The WHO's policy statement was supported by a rapid implementation document, which provided the technical "how-to" and operational considerations for rolling out the use of the assay. An unprecedented uptake of this new technology followed the release of WHO's policy: by the end of March 2014, more than 2,300 GeneXpert instruments and more than 6 million Xpert MTB/RIF cartridges had been procured in the public sector in 104 countries eligible for concessional prices.An Expert Group was convened by WHO in May 2013 to review the current body of evidence on use of Xpert MTB/RIF. The resulting recommendations from the Expert Group are included in the WHO Policy update, which widens the recommended use of Xpert MTB/RIF, including for the diagnosis of paediatric TB and on selected specimens for the diagnosis of extrapulmonary TB, and includes an additional recommendation on the use of Xpert MTB/RIF as the initial diagnostic test in all individuals presumed to have pulmonary TB.The accompanying Xpert MTB/RIF implementation manual has been developed to replace the first edition and takes into consideration the current body of evidence and operational experiences available, in the context of the Policy update.